Answers are grounded in this paper and cite their sources.
Human papillomavirus (HPV)-associated head and neck disease occurs at markedly higher rates in solid organ transplant recipients due to chronic immunosuppression, yet adult vaccination guidance for patients over 45 remains limited. We describe two heart transplant recipients, one with HPV-positive oropharyngeal squamous cell carcinoma and one with recurrent laryngeal papillomatosis, both diagnosed well beyond current Advisory Committee on Immunization Practices vaccination age thresholds. These cases highlight a preventive care gap warranting formal study in this high-risk population.
No takes yet. Share an insight, caveat, or question.
Wimbish et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: